Human neutrophils recognize group B streptococci via formylated peptide receptors and toll-like receptor 8 - Report - MDSpire

Human neutrophils recognize group B streptococci via formylated peptide receptors and toll-like receptor 8

  • By

  • Luigi Fiore

  • Giuseppe Valerio De Gaetano

  • Federica Grasso

  • Francesco Coppolino

  • Agata Famà

  • Mariachiara Stifano

  • Annamaria Petrungaro

  • Federica Vita

  • Eugenia Quartarone

  • Chiara Cipollina

  • Germana Lentini

  • Concetta Beninati

  • May 4, 2026

  • 0 min

Share

Clinical Report: Human Neutrophils Detect Group B Streptococcus

Overview

Revise to emphasize the broader implications of neutrophil function in GBS infections.

Background

Group B Streptococcus (GBS) is a significant pathogen responsible for severe infections, particularly in vulnerable populations such as newborns and the elderly. Understanding how neutrophils detect and respond to GBS is crucial for developing effective therapeutic strategies and improving clinical outcomes in infected patients. The innate immune response, particularly through neutrophils, plays a vital role in controlling GBS infections.

Data Highlights

No numerical data or trial data presented in the article.

Key Findings

Rephrase findings for clarity and ensure they are fully supported by the source.

Clinical Implications

The findings suggest that targeting the pathways involving FPR1, FPR2, and TLR8 may enhance neutrophil function and improve host defense against GBS infections. Understanding these mechanisms could inform the development of new therapeutic approaches aimed at boosting innate immune responses.

Conclusion

This research provides valuable insights into the molecular mechanisms by which neutrophils detect GBS, highlighting potential targets for therapeutic intervention in bacterial infections.

References

  1. The Journal of Infectious Diseases, 2023 -- FGF8 Protects Against Polymicrobial Sepsis by Enhancing the Host's Anti-infective Immunity
  2. Infection, 2023 -- Identification of Streptococcus pyogenes in an Uncommon Hematological Diagnostic Scenario
  3. The Journal of Infectious Diseases, 2023 -- Variability in Naturally Acquired Immunity to Group B Streptococcus: A Comparative Analysis of Women from Bangladesh, Malawi, and the UK
  4. The Journal of Infectious Diseases, 2023 -- Serological Responses to Target Streptococcus pyogenes Vaccine Antigens in Patients With Proven Invasive β-Hemolytic Streptococcal Infections
  5. Clinical Guidelines for Group B Strep Disease | Group B Strep | CDC, 2025
  6. Group B Streptococcal Disease, CDC, 2025
  7. Pfizer Announces New England Journal of Medicine Publication on Group B Streptococcus (GBS) Maternal Vaccine Candidate | Pfizer, 2025
  8. Clinical Guidelines for Group B Strep Disease | Group B Strep | CDC
  9. Group B Streptococcal Disease
  10. Pfizer Announces New England Journal of Medicine Publication on Group B Streptococcus (GBS) Maternal Vaccine Candidate | Pfizer

Original Source(s)

Related Content